Armando Anido
2019
In 2019, Armando Anido earned a total compensation of $1.4M as Chairman of the Board and Chief Executive Officer at Zynerba Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $334,112 |
|---|---|
| Option Awards | $413,149 |
| Salary | $568,218 |
| Other | $54,092 |
| Total | $1,369,571 |
Anido received $568.2K in salary, accounting for 41% of the total pay in 2019.
Anido also received $334.1K in non-equity incentive plan, $413.1K in option awards and $54.1K in other compensation.
Rankings
In 2019, Armando Anido's compensation ranked 7,786th out of 13,971 executives tracked by ExecPay. In other words, Anido earned more than 44.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,786 out of 13,971 | 44th |
Division Manufacturing | 3,056 out of 5,695 | 46th |
Major group Chemicals And Allied Products | 1,152 out of 2,194 | 48th |
Industry group Drugs | 984 out of 1,880 | 48th |
Industry Pharmaceutical Preparations | 731 out of 1,392 | 48th |
Source: SEC filing on April 23, 2020.
Anido's colleagues
We found two more compensation records of executives who worked with Armando Anido at Zynerba Pharmaceuticals in 2019.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019